✨ InnoCellular wishes the brilliant minds in the scientific community a Merry Christmas and a HappyNewYear of 2024! 🔬May your experiments be fruitful, your hypotheses proven, and your discoveries limitless in the coming year!
👨🔬 InnoCellular is very grateful with Dr. YANG Zheng from the Tissue Engineering Program of National University of Singapore for collaborating with us on testing the MesenPlify media prototype. Together, we’re advancing the expansion of human MSCs and exploring its applications in chondrogenic therapies! ✨ Excited to witness many many chondrocytes coming from MesenPlify!
🙌 Big shoutout to Dr. Priya from Institute of Molecular and Cell Biology (IMCB) and IMCB Division of Cell Biology and Therapies for her crucial role in testing our MSC expansion prototype MesenPlify! 👩🔬 With her expertise in MSC as an ASTEM researcher, we are confident she will expand the applications of our media into new realms! Excited to […]
Thank You to Dr. Dalton Tay and Wai Kit Lam from Nanyang Technological University in joining our media trial! We can’t wait to explore the endless possibilities that this collaboration may unveil! 🚀 Thank you for being part of this exciting chapter and your support to InnoCellular . 🙌
🎉 A Heartfelt #ThankYou to Dr.Shigeki Sugii and Dr. Smarajit Chakraborty from A*STAR – Agency for Science, Technology and Research have graciously accepted our invitation for a #media #trial! 📰 🎥 Their expertise will undoubtedly add tremendous value to our project, and we’re grateful for their willingness to explore this exciting opportunity with us! 🚀🔬 Thank you again for being part of this […]
👩🔬 InnoCellular is honored to be part of #SCSS2023 and had the privilege to attend Prof. Shinya Yamanaka’s inspiring talk on the recent developments in induced pluripotent stem cells #iPSCs. 🧬 His presentation showcased the remarkable progress in reprogramming adult cells into pluripotent stem cells, offering immense potential for regenerative medicine. The ability to generate iPSCs holds promise for advanced #celltherapy, […]
Thrilled to announce the kick-off of a RCA (Research Collaboration Agreement) between Allegrow Biotech and InnoCellular ! This collaboration will see us merging our expertise, aiming to create new possibilities in the cell therapy space! 🚀 🤝 It was an absolute honor to host the Allegrow Biotech team, extending a warm welcome to Singapore! Excitingly, Allegrow Biotech, a spinoff from The Hong Kong University […]
🎉 Thrilled to share that our Chief Scientific Officer, Jonathan, recently had the incredible opportunity to visit Nankai and engage in a thought-provoking seminar on the advancements in stem cell research and expanded pluripotency. 🔬 Expanded pluripotent stem cells #EPSCs represent a promising frontier in stem cell research, offering a range of potential applications across various fields, […]
The 13th Annual Meeting of CSSCR 2023 Meeting has come to an end, and we are back! What an enriching journey it has been! 🚀 Grateful for the opportunity to connect with all our new friends in China! Let’s keep the momentum going, and looking forward to seeing you all in the future events! 💡
🙌 Congratulations to our Chief Scientific Officer, Jonathan, being awarded the Public Administration Medal at the Ministry of Trade and Industry National Awards!
We will be attending the 13th Annual Meeting of the Chinese Society for StemCell Research in Hangzhou from October 12th to 15th along with our strategic partner, Applitech! Let’s talk about the potential of stem cell therapy with InnoCellular. Looking forward to learning and sharing insights together!
It’s truly exciting to see the significant regional commitment to advancements in cell and gene therapy, and, of course, to connect with new acquaintances along the way!